Search results for "Early diagnosis"

showing 10 items of 123 documents

Strategies for the Early Diagnosis of Melanoma

2014

info:eu-repo/semantics/published

Oncologymedicine.medical_specialtySkin NeoplasmsHistologybusiness.industryMelanomaDermatologySciences bio-médicales et agricolesDiagnóstico precoz de cáncermedicine.diseasePathology and Forensic MedicineEarly DiagnosisSkin Neoplasms -- diagnosisDiagnóstico precozEarly detection of cancerInternal medicineMelanoma -- diagnosisHumansMedicinebusinessMelanomaActas Dermo-Sifiliográficas (English Edition)
researchProduct

Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib

2020

Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by neoplastic transformation of pluripotent cells due to a typical cytogenetic and molecular mutation known as Philadelphia (Ph) chromosome. In 2001, the introduction of the tyrosine kinasis inhibitor (TKI) imatinib as a therapeutic strategy for CML with PH chromosome mutation represented an important step towards treatment of these patients, and nowadays, this drug represents the gold therapeutic standard in this clinical setting. A second generation of TKIs (dasatinib, nilotinib, and bosutinib) showed an effective action in all patients with mutations resistant to imatinib. Ponatinib is a third-generation TKI an…

Oncologymedicine.medical_specialtyTyrosine kinase inhibitorReview030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsLeukemia Myelogenous Chronic BCR-ABL Positivehemic and lymphatic diseasesInternal medicinemedicineHumansNeoplastic transformation030212 general & internal medicineProtein Kinase InhibitorsTyrosine kinase inhibitorsCardiotoxicitybusiness.industryPonatinibChronic myeloid leukemiaImidazolesDisease ManagementMyeloid leukemiaImatinibPyridazinesDasatinibCardio-oncologyEarly DiagnosisNilotinibchemistryCardiovascular DiseasesPonatinibPonatinib . Tyrosine kinase inhibitors . Chronic myeloid leukemia . Cardio-oncology . ReviewCardiology and Cardiovascular MedicinebusinessBosutinibFollow-Up Studiesmedicine.drug
researchProduct

Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatect…

2014

Purpose: miRNAs are noncoding RNAs that negatively regulate target mRNA gene expression. Aberrant miRNA expression is associated with prostate cancer pathogenesis. We identified miRNAs as potential biomarkers for prostate cancer diagnosis and prognosis. Materials and Methods: Total RNA was obtained from 10 normal prostate and 50 prostate cancer samples, and analyzed using the GeneChip (R) miRNA 2.0 Array. At a median followup of 92 months (range 2 to 189) an independent cohort of 273 paraffin embedded prostate cancer samples was used for validation by quantitative reverse transcriptase-polymerase chain reaction. Another 92 urine samples from patients undergoing prostate biopsy were evaluate…

PCA3OncologyMalemedicine.medical_specialtyPathologyProstate biopsydiagnosisUrologymedicine.medical_treatmentprostatic neoplasmsProstate cancerProstateInternal medicinemicroRNAmedicineBiomarkers TumorHumansAgedRetrospective StudiesProstatectomymedicine.diagnostic_testbusiness.industryProstatectomyProstatic Neoplasmsmedicine.diseasePrognosismicroRNAsGene Expression Regulation NeoplasticProstate-specific antigenMicroRNAsmedicine.anatomical_structureReal-time polymerase chain reactionEarly Diagnosisprognosisbusinessbiological markersThe Journal of urology
researchProduct

PCR for the detection of pathogens in neonatal early onset sepsis.

2020

Background A large proportion of neonates are treated for presumed bacterial sepsis with broad spectrum antibiotics even though their blood cultures subsequently show no growth. This study aimed to investigate PCR-based methods to identify pathogens not detected by conventional culture. Methods Whole blood samples of 208 neonates with suspected early onset sepsis were tested using a panel of multiplexed bacterial PCRs targeting Streptococcus pneumoniae, Streptococcus agalactiae (GBS), Staphylococcus aureus, Streptococcus pyogenes (GAS), Enterobacteriaceae, Enterococcus faecalis, Enterococcus faecium, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium, a …

PhysiologyArtificial Gene Amplification and ExtensionPathology and Laboratory Medicinemedicine.disease_causePolymerase Chain ReactionUreaplasmaUreaplasmaMycoplasma0302 clinical medicineAntibioticsRNA Ribosomal 16SMedicine and Health Sciences030212 general & internal medicineAge of OnsetCandidaMultidisciplinaryNeonatal sepsisAntimicrobialsQCandidiasisRDrugsPneumococcusBacterial InfectionsBacterial PathogensBody FluidsBloodMedical MicrobiologyInfant Extremely PrematureMedicinePathogensNeonatal SepsisAnatomyInfant PrematureResearch ArticleStaphylococcus aureusScienceMycoplasma hominisBiologyResearch and Analysis MethodsReal-Time Polymerase Chain ReactionMicrobiologyDNA RibosomalSensitivity and SpecificityMicrobiology03 medical and health sciencesSigns and SymptomsEnterobacteriaceaeDiagnostic MedicineSepsisMicrobial Control030225 pediatricsStreptococcus pneumoniaemedicineHumansMolecular Biology TechniquesMicrobial PathogensMolecular BiologyPharmacologyBacteriaOrganismsInfant NewbornBiology and Life SciencesNeonatesStreptococcusMycoplasmamedicine.diseasebiology.organism_classificationEarly DiagnosisStreptococcus agalactiaeMultiplex Polymerase Chain ReactionEnterococcusDevelopmental BiologyUreaplasma urealyticumEnterococcus faecium
researchProduct

New horizons in early stage COPD--improving knowledge, detection and treatment.

2011

SummaryEarly stage COPD carries a significant healthcare burden that is currently underrecognised, underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to advanced disease, especially if they continue to smoke. The natural history of the disease in early stages remains largely unknown, and emerging evidence indicates that we are able to reduce lung function decline and exacerbations, and improve quality of life, in early stage COPD, mainly through smoking cessation. But new evidence from randomised clinical trials also suggests an impact of pharmacotherapy on clinical outcomes in early disease. Guidelines need to be updated to reflect this greater underst…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyHealth Knowledge Attitudes Practicemedicine.medical_treatmentDiseasePulmonary Disease Chronic ObstructiveQuality of life (healthcare)PharmacotherapyHealth careDiagnosismedicineCOPDHumansIntensive care medicineCOPDbusiness.industryCase-findingEarly diseasemedicine.diseasePrognosisBronchodilator AgentsClinical trialNatural historyTreatmentEarly DiagnosisSpirometryPractice Guidelines as TopicPhysical therapyQuality of LifeSmoking cessationFemaleSmoking CessationbusinessRespiratory medicine
researchProduct

Early development of children at familial risk for Dyslexia—follow-up from birth to school age

2004

We review the main findings of the Jyväskylä Longitudinal study of Dyslexia (JLD) which follows the development of children at familial risk for dyslexia (N = 107) and their controls (N = 93). We will illustrate the development of these two groups of children at ages from birth to school entry in the skill domains that have been connected to reading and reading disability in the prior literature. At school entry, the highest score on the decoding task among the poorer half (median) of the at risk children--i.e. of those presumably being most likely genetically affected--is 1 SD below the mean of the control group. Thus, the familial risk for dyslexia shows expected consequences. Among the e…

Reading disabilityLongitudinal studyDevelopmental Disabilitiesmedia_common.quotation_subjectExperimental and Cognitive PsychologyRisk AssessmentEducationDevelopmental psychologyDyslexiaReading (process)Developmental and Educational PsychologymedicineCognitive developmentHumansLanguage Development DisordersChildmedia_commonDyslexiaInfantGeneral Medicinemedicine.diseaseChild developmentVocabulary developmentEarly DiagnosisChild PreschoolPsychologyRisk assessmentDyslexia
researchProduct

Detección precoz de la hipoacusia, influencia en el diagnóstico y en el tratamiento temprano

2021

Detección precoz de la hipoacusia, influencia en el diagnóstico y en el tratamiento temprano. INTRODUCCIÓN: La hipoacusia es el déficit sensorial mas frecuente en los países desarrollados. La prevalencia de cualquier grado de hipoacusia es de un 2-3 % de la población infantil y el 80% de las mismas, está presente al nacimiento. Los programa de screening auditivo (SA) se justifican por la alta incidencia de la hipoacusia y sus consecuencias devastadoras para el lenguaje cuando no se detecta precozmente. OBJETIVO: Establecer el número de niños diagnosticados de hipoacusia congénita gracias al SA en el hospital Universitario La Fe. Analizamos las técnicas utilizadas en el cribado, los parámetr…

age at screenotoacoustic emissions:CIENCIAS MÉDICAS [UNESCO]neonatal hearing screeninguniversal newborn hearing screeningearly interventionautomated auditory brainstem responsehearing impairment aetiologyevoked potentials auditoryUNESCO::CIENCIAS MÉDICASrisk factorsepidemiologyreferral ratecongenital hearing lossearly diagnosis
researchProduct

Role of biomarkers in monitoring antiblastic cardiotoxicity

2016

Early detection of anticancer drug-induced cardiotoxicity (CTX) has been evaluated by most international scientific cardiology and oncology societies. High expectations have been placed on the use of specific biomarkers. In recent years, conventional biomarkers and molecules of more recent interest have been tested and compared in the context of anticancer drug-related CTX. Encouraging results were obtained from studies on molecules of myocardial damage, such as troponin and markers of myocardial wall stress, including circulating natriuretic peptides, as well as from the assessment of the products of inflammation or circulating levels of free radicals. However, clear guidelines on their se…

cardiac toxicitymedicine.medical_specialtyantiblasticantineoplasticEarly detectionContext (language use)Antineoplastic Agentsantiblastic; anticancer drugs; antineoplastic; biomarkers; brain natriuretic peptide; cardiac toxicity; troponin; Cardiology and Cardiovascular Medicine030204 cardiovascular system & hematologyBioinformaticsbrain natriuretic peptideSensitivity and Specificity03 medical and health sciencesWall stress0302 clinical medicineCardiac toxicityNeoplasmsNatriuretic Peptide BrainmedicineHumansanticancer drugIntensive care medicineantineoplastic antiblastic anticancer drugs biomarkers brain natriuretic peptide cardiac toxicity troponinMonitoring PhysiologicCardiotoxicitybusiness.industrytroponinbiomarkersGeneral MedicineTime optimalCardiotoxicityanticancer drugsEarly DiagnosisCardiovascular Diseases030220 oncology & carcinogenesisbiomarkerbusinessCardiology and Cardiovascular Medicine
researchProduct

Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey

2022

Spondyloarthritis are chronic inflammatory diseases affecting spine, peripheral joints and enthesis, as well as extra-articular sites (bowel, eyes, skin). Diagnosis of spondyloarthritis often is slow and requires a multidisciplinary approach. The “Early SpA Clinic” project aimed at improving the patient care and journeys, by solving some organizational issues existing in Rheumatology Clinics. The “Early SpA Clinic” involved 19 Italian Rheumatology Centers using in-depth organizational analyses to identify areas for improvement. From the results of the analyses, some organizational solutions were suggested, and their impact measured at the end of the project through specific KPI. With the im…

hospital organizationSettore MED/16 - REUMATOLOGIAspondyloarthritis.Early SpA Clinicearly diagnosipatient journeyrheumatologyGeneral MedicineEarly SpA Clinic; early diagnosis; hospital management; hospital organization; patient journey; rheumatology; spondyloarthritis.hospital managementspondyloarthritisearly diagnosis
researchProduct

Prepare the smoking cessation in severe mental illness: Early diagnosis and prevention opportunities

2019

medicine.medical_specialtyBipolar Disorderbusiness.industrymedicine.medical_treatmentSmokingMEDLINESmoking PreventionHealth PromotionGeneral MedicineMental illnessmedicine.diseaseEarly DiagnosisPatient Education as TopicSchizophrenic PsychologymedicineHumansSmoking cessationSchizophrenic PsychologySmoking CessationPsychiatrybusinessRandomized Controlled Trials as TopicRevista de Psiquiatría y Salud Mental (English Edition)
researchProduct